Web Analytics Made Easy - StatCounter

Dermatology Medicines Tenders

Get complete information related to latest Dermatology Medicines Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Dermatology Medicines Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Dermatology Medicines Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Central Government/Public Sector

CTN :44438927 Due date: 13 Apr, 202613 Apr, 2026 NA
Tender For corrigendum : rate contract for supply of medicines,surgical items & consumables against day to day local purchase,of kg hospital,clw for a period of two years from the date of commencement of the contract

corporations/Associations/Others

CTN :44845367 Due date: 22 Apr, 202622 Apr, 2026 5.00 Lacs
Tender For providing of local chemist empanelment service - branded medicines; 0-15 km(s),local chemist empanelment service - branded medicines; 0-15 km(s),local chemist empanelment service - branded medicines; 0-15 km(s),local chemist empanelment service - generic medicines; 0-15 km(s),local chemist empanelment service - generic medicines; 0-15 km(s),local chemist empanelment service - generic medicines; 0-15 km(s),local chemist empanelment service - surgical consumable items; 0-15 km(s),local chemist empanelment service - surgical consumable items; 0-15 km(s),local chemist empanelment service - surgical consumable items; 0-15 km(s)

CTN :44845621 Due date: 20 Apr, 202620 Apr, 2026 1.44 Crore
Tender For providing of local chemist empanelment service - any medicines as per requirement; 50 kms

CTN :44845866 Due date: 01 May, 202601 May, 2026 48.60 Lacs
Tender For providing of bio medical waste management service - per bed basis - transportation, treatment, disposal, lifting; medical colleges & institutions; animal waste, human anatomical, medicines, broken glass, syringes, scalpels, injections & needles, chemical disinfec..

CTN :44845889 Due date: 28 Apr, 202628 Apr, 2026 NA
Tender For providing of local chemist empanelment service - generic medicines; 200 kms

Central Government/Public Sector

CTN :44699723 Due date: 13 Apr, 202613 Apr, 2026 NA
Tender For corrigendum : supply of ayurvedic classical medicines - arishta (q1) , ayurvedic classical medicines - guggulu (q1) , ayurvedic classical medicines - choorna (q1) , ayurvedic classical medicines - taila (q1) , ayurvedic classical medicines (kvatha) (q1) , ayurvedic classical medicines - vati and gutika (q1) , ayurvedic classical medicines -bhasma (q1) , ayurvedic classical medicines - avaleha and pak (q1) , ayurvedic classical medicines - mandoor (q1) , ayurvedic classical medicines (asava) (q1)

Corporations And Associations And Others

CTN :44431221 Due date: 20 Apr, 202620 Apr, 2026 NA
Tender For corrigendum : purchase of vet medicines

corporations/Associations/Others

CTN :44434766 Due date: 12 May, 202612 May, 2026 NA
Tender For corrigendum : supply of drugs/medicines - metoclopramide inj- each ml to contain: metoclopramide hcl eqv. to metoclopramide 5 mg packing: 2ml amp, promethazine syp-each 5 ml to contain: promethazine 5mg packing: 100ml bottle, promethazine inj-each ml to contain: promethazine 25mg, packing: 2ml vial/amp, artificial tears drop-each vial to contain: polyvinyl alcohol 1.4%, povidone 0.6%, benzalkonium chloride 0.01%packing:10ml vial, sodium hyaluronate inj (intra articular)-each pfs to contain: sodium hyaluronate 25mg, sodium chloride, sodium phosphate dibasic and monobasic q.s., packing: 1 pfs, tropicamide eye drop-each vial to contain: tropicamide 0.8%, phenyl ephrine hcl 5% packing:5ml vial, ibuprofen oral susp-each 5 ml to contain: ibuprofen 100 mg packing:60ml bottle, indomethacin tab/cap-each tab/cap to contain: indomethacin 25 mg, indomethacin sr tab/cap-each sr tab/cap to contain: indomethacin 75 mg, antibiotic eye oint-each gram to contain: polymyxin b sulphate 5000 iu, neomycin sulphate 3400 iu, zinc bacitracin 400 iu, hydrocortisone 10 mg in white sterilised petroleum jelly base.packing:5gm tube, flurbiprofen eye drop-each vial to contain: flurbiprofen 0.03% w/v packing:5ml vial, polymixin, neomycin eye oint-each gm to contain: polymixin b sulphate 5000 iu, neomycin sulphate 3400 iu, zinc bacitracin 400 iu 5gm to 10gm tube, antacid gel-each 5ml to contain: aluminium hydroxide 6g, mag. hydroxide 80mg., activated dimethicone 100mg, deglycycrrhizinated liquorice eqv. to liquorice 400mg.,packing: 180ml bottle, otilonium bromide tab/cap-each tab/cap to contain: otilonium bromide 40mg, euphorbia prostata tab/cap -each tab/cap to contain: euphorbia prostata dry extract ethanolic 80% (v/v) 100mg, paracetamol inj -each ml to contain: paracetamol 10 mg,100ml bottle, dorzolamide+timolol eye drop-each vial to contain: dorzolamide 2% ,timolol i.p. 0.5%, packing:5ml vial, tocilizumab inj 80mg -each vial to contain: tocilizumab 80 mg, packing: 4ml vial, tocilizumab inj 200mg -each vial to contain: tocilizumab 200 mg, packing: 10ml vial, tocilizumab inj 400mg -each vial to contain: tocilizumab 400 mg, packing: 20ml vial, racecadotril dispersible tab/cap-each disp tab/cap to contain: racecadotril 10mg, racecadotril dispersible tab/cap-each disp tab/cap to contain: racecadotril 30mg, haemorrhoidal cream-each gm to contain: euphorbia prostrata dry extract ethanolic 80% (v/v)((35-70):1) 10 mg (containing 0.315 -0.825 mg total flavonoids calculated as apigenin-7 glucoside and 1.26-4.40 mg total phenolics calculated as gallic acid)cream base q.s.packing:30gm tube, buprenorphine transdermal patch - each transdermal patch to contain :buprenorphine 5 mcg/hr. area containing active substance 6.25sqcm,6.25sqcm patch, buprenorphine transdermal patch - each transdermal patch to contain : buprenorphine 10 mcg/hr. area containing active substance 12.5sqcm,12.5sqcm patch, buprenorphine transdermal patch - each transdermal patch to contain :buprenorphine 20 mcg/hr. area containing active substance 25sqcm,25sqcm patch, analgesic cream-each tube to contain: methyl salicylate 30% w/w, menthol 10% w/w, camphor 4 % w/w, excipients q.s. packing:30 gm tube, misoprostol tab/cap-each tab/cap to contain : misoprostol 25mcg, dorzolamide eye drop-each vial to contain: dorzolamide 2% packing:5ml vial, metronidazole oral gel-each tube to contain: metronidazole 1%, chlorhexidine 0.25% packing:20gm tube, prucalopride tab/cap-each tab/cap to contain: prucalopride 1mg, pancreatin + activated dimethicone tab/cap-each enteric coated tab/cap to contain: pancreatin 170mg, activated dimethicone 80mg, lubricating eye drop-each vial to contain: povidone 20mg/ml, preservative free, phosphate free, packing: 10ml vial, antacid syp-each 5ml to contain: aluminium hydroxide paste eqv. to dried aluminium hydroxide gel i.p 300 mg, magnesium hydroxide paste eqv. to magnesium hydroxide i.p 250 mg, activated dimethicone i.p 40mg, sorbitol solution i.p 1000mg,170ml bottle, essential phosp

corporations/Associations/Others

CTN :44434772 Due date: 12 May, 202612 May, 2026 NA
Tender For corrigendum : supply of drugs/medicines - 5-aminosalicylic acid (mesalazine/ mesalaine) retention enema: each 60ml unit of rectal suspension contains mesalazine/mesalamine 4.0 gramspacking:60ml bottle, mesalazine/ mesalaine suppository-each suppository to contain: mesalazine/ mesalaine 500mg, mercaptopurine tablet-each tab to contain: mercaptopurine 50mg, abacavir + lamivudine tablet: each tab to contain: abacavir 60 mg + lamivudine 30 mg, abacavir + lamivudine tablet: each tab to contain: abacavir 600 mg + lamivudine 300 mg, abacavir tablet: each tablet to contain: abacavir 60mg, acetyl salicylic acid tab-each enteric coated tablet to contain: acetyl salicylic acid 100mg, actinomycin d inj-each vial to contain: actinomycin d 0.5mg packing:1 vial, activated charcoal powder packing:100gm, acyclovir inj-each vial to contain: acyclovir 250mg packing:1 vial, acyclovir oral suspension-each 5ml to contain: acyclovir 400 mg, packing:100ml bottle, acyclovir tab-each tablet to contain: acyclovir 800mg., allopurinol tab -each tablet to contain: allopurinol 300 mg, all-trans retinoic acid cap-each capsule to contain all trans retinoic acid 10mg, alprostadil inj- each ml to contain alprostadil 500mcg packing:1ml vial/amp, amoxycillin oral suspension - each 5 ml to contain: amoxycillin 250 mg, packing:100ml bottle, amoxicillin inj-each vial to contain: amoxicillin 1000 mg packing:1 vial, amoxicillin inj-each vial to contain: amoxicillin 250 mgpacking:1 vial, amoxicillin inj-each vial to contain: amoxicillin 500 mg packing:1 vial, lipid amphotericin b inj-each vial to contain: lipid amphotericin b 50 mg packing:1 vial, ampicillin inj-each vial to contain: ampicillin 1000 mg(1gm) packing:1 vial, arsenic trioxide inj-each ml to contain arsenic trioxide 1mg packing:10ml vial, artemether & lumefantrine tablet-each tablet to contain: artemether 40mg and lumefantrine 240mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 150mg (b)2 tablets of sulphadoxine 500mg & pyrimethamine 25mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 25mg (b) 1 tablet of sulphadoxine 250mg & pyrimethamine 12.5mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 50mg (b) 1 tablet of sulphadoxine 500mg & pyrimethamine 25mg, anti-malarial kit-each combikit to contain: (a) 1 tablet of artesunate 100mg (b) 1 tablet of sulphadoxine 750mg & pyrimethamine 37.5mg, artesunate inj- each vial to contain:artesunate 120 mg packing:1 vial, atazanavir + ritonavir tab-each tablet to contain atazanavir 300 mg+ritonavir 100 mg, atropine eye drop: each ml to contain atropine 1% packing:5ml vial, azathioprine tab-each tablet to contain: azathioprine 25 mg, baclofen tab-each tablet to contain: baclofen 20 mg, barium sulphate oral liquid-barium sulphate 95% w/v, packing:500ml bottle, bedaquilinetab-each tablet to contain: bedaquiline 100 mg, bendamustine inj-each vial to contain: bendamustine hydrochloride 25mg packing:1 vial, betamethasone valerate cream- each gm to contain betamethasone valerate0.05 %packing:15gm tube, betamethasone valerate cream- each gm to contain betamethasone valerate 0.1%packing:15gm tube, bisacodyl suppository-each suppository to contain: bisacodyl 5mg, bisacodyl tab--each tablet to contain: bisacodyl 5 mg, budesonide nasal spray-each actuation to deliver: budesonide 50 mcg. packing:100 to 150 doses, bupivacaine injection 0.5 % with 7.5 % glucose packing:4ml amp, caffeine inj-each ml to contain: caffeine citrate 20mg packing: 2ml vial/amp, caffeine oral solution- each ml to contain: caffeine citrate 20mg packing: 3 ml bottle, calcium carbonate tablet- each tablet to contain calcium carbonate 625 mg (equivalent to elemental calcium 250 mg), calcium folinate inj-each ml to contain: calcium folinate 3mg packing: 1ml vial/amp, calcium folinate tab-each tab to contain: calcium folinate 15mg, carbamazepine oral liquid-each 5ml to contain: carbamazepine 100mg, packing:100 ml bottle, c

corporations/Associations/Others

CTN :44434778 Due date: 12 May, 202612 May, 2026 NA
Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap
 Loading, Please wait...

Connect us via What's Up